Clinical and research tests for C0013264 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 24

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Inheritest 500 PLUS Panel Integrated Genetics Westborough LabCorp United States	287	578	D Deletion/duplication analysis E Sequence analysis of select exons C Sequence analysis of the entire coding region
DMD-NGS-S Baylor Genetics United States	1	1	E Sequence analysis of select exons
DMD Prenatal Sequence Analysis (GeneAware) (Prenatal Sequence Analysis) Baylor Genetics United States	1	1	E Sequence analysis of select exons
Factor II and Factor V Leiden Panel NxGen MDx United States	6	6	D Deletion/duplication analysis E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon 14 Natera, Inc. United States	15	15	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 106 plus TSE Natera, Inc. United States	103	107	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 27 Natera, Inc. United States	28	28	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 106 Natera, Inc. United States	103	106	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 27 plus TSE Natera, Inc. United States	28	29	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 274 Plus TSE Natera, Inc. United States	265	275	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 274 Natera, Inc. United States	265	274	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 137 plus TSE Natera, Inc. United States	135	138	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 137 Natera, Inc. United States	135	137	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 274 Natera, Inc. United States	265	274	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 14 plus TSE Natera, Inc. United States	15	16	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon 14 Natera, Inc. United States	15	15	E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Horizon Duchenne Muscular Dystrophy, Cystic Fibrosis and Spinal Muscular Atrophy Natera, Inc. United States	4	3	E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon Duchenne Muscular Dystrophy, Spinal Muscular Atrophy and Tay Sachs Enzyme Natera, Inc. United States	4	3	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon Duchenne Muscular Dystrophy, Cystic Fibrosis, Spinal Muscular Atrophy and Tay Sachs Enzyme Natera, Inc. United States	5	4	E Enzyme assay E Sequence analysis of select exons C Sequence analysis of the entire coding region
Horizon DMD and Spinal Muscular Atrophy Natera, Inc. United States	3	2	E Sequence analysis of select exons C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 24

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.